Podcast: The Productivity of Defense Independent R&D

George Mason University and Wharton Aerospace Community held an excellent event on the productivity of independent research and development (IR&D). Discussing the topic was an insightful panel including former ASD(A) Kevin Fahey, defense analyst Byron Callan, and former Acquisition Talk guest Anne Marie Knott moderated by Stephanie Halcrow, senior fellow at GMU’s Center for Government Contracting.

IR&D, of course, in the defense world is different than the R&D done at commercial firms like Google and Netflix. IR&D projects are funded by defense contractors, but the cost is reimbursed by government as an indirect rate spread across their portfolio of contracts. (You can find more about that in the forward pricing rate process). This provides for some interesting incentives and comparisons with the commercial sector. The panelists discuss:

  • Whether defense contractors spend enough on IR&D
  • Rates of return on corporate venture capital
  • The effect of profit policy on IR&D
  • How to align contractor IR&D with defense objectives
  • How the Research Quotient can be used to benchmark IR&D

How IR&D is different

Here’s Kevin Fahey discussing the crux of the issue:

We [the government] reimburse independent R&D as allowable costs, and oh, by the way, if you’re competing for a government contract, we get full disclosure of your cost and pricing. The most profit you’ll make is 15%.

 

None of that math happens in commercial market. They invest a lot in R&D because they let the commercial market drive what they’re going to get for their product. The iPhone, I guarantee you, is making more than 15% profit.

If a commercial company invests in a differentiated product that is far better than any competitor, then they can create substantial profitability at the same time they better serve the customer. Put in another way, the company that reduces production costs by 50% and reduces the price by only 25% still does the consumer a great benefit. But the company can only maintain those margins so long as they stay ahead of innovating competitors.

Defense profits, however, are basically capped at 15% — meaning there is not the same upside to independent R&D. The bulk of defense R&D is performed under contract rather than at the initiative of private companies.

Byron Callan found that defense companies like Lockheed and Northrop spent roughly 2% of sales on R&D annually back to the 1960s, so there hasn’t been much change in R&D intensity. Byron reported how in one case, Northrop self-funded the F-20 Tigershark in the 1980s which grew to 12% of sales. Northrop learned a hard lesson, however, when the Air Force declined to buy the aircraft. Northrop bet that the Air Force valued low production and sustainment costs, when in fact the Air Force wanted high-end capability at any price.

Direction of IR&D

The GAO recently reported that defense contractors were largely not spending their IR&D dollars on capabilities that aligned with top priority areas identified by USD R&E such as hypersonics, autonomy, directed energy, and cyber. But that misalignment — if that’s indeed what it is — is largely due to the incentives DoD puts on contractors. The mark of success is whether an effort transitions into a program of record, which locks up funding for many years and often protects a contractor from competition. Here’s Kevin Fahey:

The defense industrial base spend their money on is what they’re incentivized to spend their money on… We tend to incentivize them mostly to spend their money on winning the next project. Not necessarily, quantum stuff, because quantum stuff is 10 years away or whatever it is. It’s how do I win a program tomorrow?

For that reason, we tend to hear how contractors want clarity on government requirements so they know where to spend their IR&D dollars. Here’s Kevin:

… to a large extent, the industry invests where they believe they’re going to get a return on investment. And so part of the struggle — and continuous struggle — is how do we get better transparency that they have as a good as understanding as the government of what the needs are.

I struggle with this because commercial sector firms make investments based on their speculation about where the market is going. Some win, others lose. Some make big profits, others make big losses. Having the government lead industry in terms of its technology development is in many cases backwards to the concept of IR&D since industry has greater technical expertise. And in any case, DoD provides greater insight into its programs over the upcoming 5 years than any other nation. These programs are telegraphed years in advance due to the bureaucratic processes. Major contractors have the inside baseball on where programs are likely to go already.

Prime Contractor Venture Capital

One of Anne Marie’s findings is that when a company outsources R&D, it gets basically zero return on that investment. Byron brought up the point that a lot of contractor technology development isn’t done through IR&D or outsourced R&D, but through acquisitions and venture investing.

Lockheed in their latest reports has realized a $54 million gain [from venture activity]. If outsourced is including venture activity, there’s really a lot going on there. It’s helped people like L3 position on unmanned, autonomous naval vessels.

Anne Marie clarified that the average productivity of outsourced R&D — when the company pays another company to do R&D on it’s behalf — is zero. She provides a couple interesting points:

The preliminary evidence is that acquisitions are okay as long as they’re small relative to the scale of the company, meaning that, this is a nice marriage where the small company gets the benefit of the big company.

 

…the corporate venture funds are actually more productive than independent venture funds. Not everybody knows that. And that’s because they’ve got in-depth expertise.

Thanks!

I’d like to thank Ellen Chang for getting the ball rolling on this event. She has an excellent write-up of the discussion here. I’d also like to thank Stephanie Halcrow, Kevin Fahey, Bryon Callan, and Anne Marie Knott for sharing their time and expertise. Be sure to listen to the whole thing! You can also watch the webinar video on YouTube. Here are some additional links:

Full-Text Transcripts

Be the first to comment

Leave a Reply